Cryptogenic Hepatitis and Bartonellosis

2012 ◽  
Vol 57 (4) ◽  
pp. 1107-1108 ◽  
Author(s):  
Paulo Eduardo Neves Ferreira Velho ◽  
Marna Elise Ericson
2019 ◽  
Vol 64 (9) ◽  
pp. 565-570 ◽  
Author(s):  
Yu. V. Ostankova ◽  
A. V. Semenov ◽  
Areg A. Totolian

To analyze the method HBV covalent-closed circular DNA quantitative determination in liver puncture biopsies and evaluate its significance in identifying HBsAg-negative viral hepatitis B. In this work, samples of liver tissue biopsy material were used from 128 patients living in St. Petersburg, in various regions of the Russian Federation, as well as in the Republic of Uzbekistan. For quantitative analysis of HBV covalently closed circular DNA in a biopsy material a method was developed based on real-time PCR using TaqMan probes for the target fragment and for the endogenous reference gene, based on the detecting ccc HBV DNA method of Pollicino T. et al. When quantifying ccc DNA HBV in liver tissue of 18 moderately HBV activity with HBV DNA PCR positive results patients and 16 inactive HBsAg carriers, the ccc DNA HBV content was significantly different between groups (p<0.034) and in terms 1 copy of the β-globin gene among moderate activity HBV patients amounted to 1.71±1.32 copies/cell, and for inactive HBsAg carriers 0.15±0.14 copies/cell. In the group of patients with severe liver fibrosis and cirrhosis, the amount of ccc DNA HBV in liver tissue in patients with HBV averaged 2.5±0.4 copies/cell, in patients with HBV + D on average 0.7±0.25 copies/cell, in patients with HCV + HBV co-infection 0.45±0.07 copies/cell, in patients with a preliminary diagnosis of chronic hepatitis C hepatitis, on average 0.12±0.04 copies/cell, in patients with cryptogenic hepatitis 0.2± 0.05 copies/cell. A significant difference was shown between the group of patients with chronic hepatitis B with marked fibrosis and cirrhosis of the liver with other patients groups, except for the group of 18 moderate activity chronic hepatitis B patients. The values of Student’s t-test when compared with other groups were respectively: for patients with a HCV preliminary diagnosis t=5,92 p<0,05 f = 19, patients with cryptogenic hepatitis t=5,71 p<0,05 f = 18, with «inactive HBsAg carriage» t=5,55 p<0,05 f = 29, with HCV + HBV co-infection t=5,05 p<0,05 f = 15 and HBV + D co-infection t=3,82 p<0,05 f = 17. The covalently closed circular DNA HBV quantitative assessment method in liver puncture biopsies allows identifying HBsAg-negative chronic viral hepatitis B forms and also reflects the virus replication activity, which, in turn, makes it possible to assume further disease progression and evaluate the antiviral therapy effectiveness.


2007 ◽  
Vol 45 (1) ◽  
pp. 15-19 ◽  
Author(s):  
A Potthoff ◽  
K Deterding ◽  
C Trautwein ◽  
P Flemming ◽  
C Strassburg ◽  
...  

2011 ◽  
Vol 49 (01) ◽  
Author(s):  
M Zierden ◽  
A Penner ◽  
M Montesinos-Rongen ◽  
M Weferling ◽  
U Drebber ◽  
...  

2017 ◽  
Vol 89 ◽  
pp. 10-13 ◽  
Author(s):  
Sook-Hyang Jeong ◽  
Byung-Joo Park ◽  
Yong-Hyun Kim ◽  
Yun Suk Choi ◽  
Hee-Seop Ahn ◽  
...  

2000 ◽  
Vol 145 (1) ◽  
pp. 73-84 ◽  
Author(s):  
M. N. Al-Ahdal ◽  
M. A. Rezeig ◽  
G. Kessie ◽  
F. Chaudhry ◽  
F. J. Al-Shammary

2007 ◽  
Vol 31 (6) ◽  
pp. 373-377 ◽  
Author(s):  
Paulo Eduardo Neves Ferreira Velho ◽  
Vanessa Pimentel ◽  
Gilda Maria Barbaro Del Negro ◽  
Thelma Suely Okay ◽  
Pedro Paulo Vissotto de Paiva Diniz ◽  
...  

2012 ◽  
Vol 460 (4) ◽  
pp. 389-397 ◽  
Author(s):  
Mario Zierden ◽  
Arndt-Hendrik Penner ◽  
Manuel Montesinos-Rongen ◽  
Maren Weferling ◽  
Uta Drebber ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Yuko Nagaoki ◽  
Hideyuki Hyogo ◽  
Yuwa Ando ◽  
Yumi Kosaka ◽  
Shinsuke Uchikawa ◽  
...  

Abstract Background We previously reported on the trends in the etiologies of hepatocellular carcinoma (HCC) diagnosed in patients between 1995 and 2009. The aims of our updated study were to evaluate the incidence, nonhepatitis B and nonhepatitis C viral (NBNC) etiologies, and clinical characteristics of HCCs occurring in patients between 1992 and 2018. Methods The study enrolled 2171 consecutive patients with HCC between 1992 and 2018. Their medical records were reviewed. The patients were divided into two groups, patients with early diagnoses from 1992 to 2009 and those with late diagnoses from 2010 to 2018. Results NBNC-HCC occurred in 514 patients (23.6%). The percentage of patients with HCC who had NBNC-HCC increased from 26.5% in 2009 to 46.3% in 2018. Patients with NBNC-HCC were older (median ages from 67 to 73 years). Type 2 diabetes mellitus (48.5–60.3%: P = 0.008), hypertension (48.5–57.4%: P = 0.047), and hyperlipidemia (39.2–53.8%: P = 0.001) increased significantly in recent years. The median FIB-4 index decreased (4.37–3.61: P = 0.026) and the median platelet count increased (15.1–17.9 × 104/μL: P = 0.013). Among the 514 patients with NBNC-HCC, 194 underwent hepatic resection for nonalcoholic steatohepatitis (NASH) (15%), alcoholic liver disease (ALD) (29%), and cryptogenic hepatitis (56%). Cirrhosis was detected in 72%, 39%, and 16% of patients with NASH, ALD, and cryptogenic hepatitis, respectively. The prevalence of cirrhosis in patients with NASH was significantly higher than the prevalence of cirrhosis in the other groups (P < 0.001). Overall, 70% of the non-malignant liver tissue of patients with NBNC-HCC was not involved with cirrhosis. On the other hand, the median FIB-4 index in patients with cryptogenic HCC was 2.56, which was a significantly lower value than those values in the other groups of patients. The FIB-4 index considered as one of useful screening of HCC. Conclusions The prevalence of NBNC-HCC has increased rapidly even in a regional university hospital. Metabolic syndrome may be an important risk factor for HCC. HCC was also found in patients with non-cirrhotic livers. The FIB-4 index may be a useful screening method for HCC in patients with NBNC.


Sign in / Sign up

Export Citation Format

Share Document